Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

Tafamidis in Transthyretin Amyloid Cardiomyopathy: Effects on Transthyretin Stabilization and Clinical Outcomes

(2015) M. S. Maurer et al.   Circulation-Heart Failure

The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis

(2014) Amanda Tendler et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

How to Image Cardiac Amyloidosis

(2014) Rodney H. Falk et al.   Circulation-Cardiovascular Imaging

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes

(2014) M. Senni et al.   EUROPEAN HEART JOURNAL

Heart failure with preserved ejection fraction: a clinical dilemma

(2014) M. Komajda et al.   EUROPEAN HEART JOURNAL

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

(2014)   EUROPEAN HEART JOURNAL

Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy

(2014) Simone Longhi et al.   JACC-Cardiovascular Imaging

Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis

(2014) David F. Hutt et al.   European Heart Journal-Cardiovascular Imaging

Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction

(2014) Selma F. Mohammed et al.   JACC-Heart Failure

Developing Therapies for Heart Failure With Preserved Ejection Fraction

(2014) Javed Butler et al.   JACC-Heart Failure

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Age-Related Oxidative Modifications of Transthyretin Modulate Its Amyloidogenicity

(2013) Lei Zhao et al.   BIOCHEMISTRY

99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses

(2013) Sabahat Bokhari et al.   Circulation-Cardiovascular Imaging

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

(2013) Teresa Coelho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

(2013) Jennifer H. Pinney et al.   Journal of the American Heart Association

Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study

(2012) Laura Obici et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy

(2012) Elizabeth J. Ackermann et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Transthyretin (TTR) Cardiac Amyloidosis

(2012) Frederick L. Ruberg et al.   CIRCULATION

Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis

(2012) Dermot Phelan et al.   HEART

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

(2012) T. Coelho et al.   NEUROLOGY

Papel de la gammagrafía cardiaca con 99mTc-DPD en la discriminación del subtipo de amiloidosis cardiaca

(2012) F. Javier de Haro-del Moral et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs

(2011) Steve Bourgault et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Amiloidosis. También una enfermedad del corazón

(2011) Pablo García-Pavía et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Role of 99mTc-DPD Scintigraphy in Diagnosis and Prognosis of Hereditary Transthyretin-Related Cardiac Amyloidosis

(2011) Claudio Rapezzi et al.   JACC-Cardiovascular Imaging

Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study

(2008) Maarit Tanskanen et al.   ANNALS OF MEDICINE